Avai Bio (AVAI) Gross Profit (2019 - 2023)

Avai Bio has disclosed Gross Profit across 5 years of filings, most recently posting $1.0 for Q1 2023.

• Gross Profit for Q1 2023 came in at $1.0, up 100.0% year-over-year; the trailing twelve-month figure through Mar 2023 was -$40453.0 (down 105.88% YoY), and the FY2023 annual result was -$40453.0, up 80.81% from the prior year.
• Gross Profit came in at $1.0 for Q1 2023 at Avai Bio, up from -$71537.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $542902.0 in Q2 2021 to a low of -$262334.0 in Q1 2020.
• The 5-year median for Gross Profit is $6296.0 (2019), against an average of $51346.9.
• Across the five-year window, Gross Profit surged 1310.52% in 2020 and tumbled 206.92% in 2021, its largest moves.
• Avai Bio's Gross Profit stood at $6000.0 in 2019, then soared by 5669.9% to $346194.0 in 2020, then decreased by 15.66% to $291972.0 in 2021, then sank by 124.5% to -$71537.0 in 2022, then jumped by 100.0% to $1.0 in 2023.
• The last three Gross Profit figures came in at $1.0 (Q1 2023), -$71537.0 (Q4 2022), and $6592.0 (Q3 2022), per Business Quant data.